Xiaolong Liang
Overview
Explore the profile of Xiaolong Liang including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
199
Citations
2273
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Xu S, Gao W, Lu J, Liang X, Xu K, Liang J, et al.
ChemSusChem
. 2024 Jun;
17(23):e202400936.
PMID: 38873971
The limited visible light response is a critical drawback that hampers the photocatalytic efficacy of Ti-MOFs. However, study concerning the enhancement of the visible-light response of Ti-MOFs is still in...
22.
Yin Z, Guo X, Liang X, Wang Z
Med Oncol
. 2024 Apr;
41(5):120.
PMID: 38643333
Gastric cancer (GC) is a serious malignant tumour with a high mortality rate and a poor prognosis. Recently, emerging evidence has suggested that N6-methyladenosine (m6A) modification plays a crucial regulatory...
23.
Dou Y, Deng L, Liang X, Cao F, Chen B, Tang S, et al.
J Minim Invasive Gynecol
. 2024 Apr;
31(7):584-591.
PMID: 38642887
Study Objective: To explore the effectiveness of transvaginal natural orifice transluminal endoscopic surgery extraperitoneal sacral hysteropexy (vNOTES-ESH) in women with symptomatic uterine prolapse over a 2 year follow-up. Design: Retrospective...
24.
Zhang J, Sun L, Jiang L, Xie X, Wang Y, Wu R, et al.
Adv Sci (Weinh)
. 2024 Mar;
11(22):e2400485.
PMID: 38552151
Immunotherapy is showing good potential for colorectal cancer therapy, however, low responsive rates and severe immune-related drug side effects still hamper its therapeutic effectiveness. Herein, a highly stable cerasomal nano-modulator...
25.
Li Y, Guo X, Liang X, Wang Z
Front Biosci (Landmark Ed)
. 2024 Mar;
29(3):117.
PMID: 38538279
Background: N6-methyladenosine (m6A) modification is one of the most common RNA modifications in mammals. m6A modification, and associated abnormal gene expression, occur during various biological processes, most notably tumorigenesis. YTH...
26.
An Z, He Q, Jiang L, Wang Y, Zhang Y, Sun Y, et al.
ACS Biomater Sci Eng
. 2024 Feb;
10(3):1774-1787.
PMID: 38420991
Inflammation is considered to be the main target of the development of new stroke therapies. There are three key issues in the treatment of stroke inflammation: the first one is...
27.
Wang C, Chen J, Li J, Xu Z, Huang L, Zhao Q, et al.
J Clin Invest
. 2024 Feb;
134(8).
PMID: 38412034
Adoptive transfer of T cell receptor-engineered T cells (TCR-T) is a promising strategy for immunotherapy against solid tumors. However, the potential of CD4+ T cells in mediating tumor regression has...
28.
Zhang W, Liang X, Zhang X, Tong W, Shi G, Guo H, et al.
Eur J Nucl Med Mol Imaging
. 2024 Feb;
51(7):1841-1855.
PMID: 38372766
Purpose: Pancreatic ductal adenocarcinoma (PDAC) is a lethal hypovascular tumor surrounded by dense fibrosis. Albumin-bound paclitaxel and gemcitabine (AG) chemotherapy is the mainstay of PDAC treatment through depleting peritumoral fibrosis...
29.
Chen M, Cao X, Huang Y, Zou W, Liang X, Yang Y, et al.
Plant Sci
. 2024 Feb;
342:112038.
PMID: 38367821
Malus 'Pinkspire' is regulated by abscisic acid (ABA), which results in a red colour, but the regulatory relationship between ABA and anthocyanin synthesis has not been determined. The key factors...
30.
Zhang M, Peng X, Liang X, Wang W, Yang Y, Xu F, et al.
Clin Exp Otorhinolaryngol
. 2024 Feb;
17(2):122-136.
PMID: 38360523
Objectives: The annual prevalence of chronic rhinosinusitis (CRS) is increasing, and the lack of effective treatments imposes a substantial burden on both patients and society. The formation of nasal polyps...